Aurobindo Pharma Limited (BOM:524804)
India · Delayed Price · Currency is INR 1,641.00
-23.90 (-1.44%)
At close: Sep 16, 2026
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 945.35 billion as of September 16, 2026. Its market cap has increased by 47.96% in one year.
Market Cap
945.35B
Enterprise Value
920.14B
Revenue
349.35B
Ranking
n/a
PE Ratio
25.46
Stock Price
1,641.00
ChartMarket Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 945.35B, an increase of 9,744.00%. That is a compound annual growth rate of 20.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 945.35B | 37.59% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.89T |
| Dr. Reddy's Laboratories | 967.09B |
| Lupin | 958.36B |
| Abbott India | 543.69B |
| GlaxoSmithKline Pharmaceuticals | 480.64B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 225.41B |
| Caplin Point Laboratories | 209.39B |